Galectins and Their Functions in Plain Language

Galectins

Volumn , Issue , 2008, Pages 9-31

  Klyosov, Anatole A ^a  

^a Pro Pharmaceuticals Inc   (United States)

Author keywords

"neat" lectins and glycosylated lectins; Galectins galactose binding lectins; Galectins natural and artificial ligands

Indexed keywords

EID: 84859510271     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470378076.ch2     Document Type: Chapter

References (59)

1. Stirpe F, Hudges RC. Specificity of ribosome-inactivating proteins with RNA N-glycosidase activity. Biochem J 1989;262:1001-1002.
2. Pallanca A, Mazzaracchio R, Brigotti M, Carnicelli D, Alvergna P, Sperti S, Montanaro L. Uncompetitive inhibition by adenine of the RNA-N-glycosidase activity of ribosomeinactivating proteins. Biochem Biophys Acta 1998;1384:277-284.
3. Ackerman SJ, Liu L, Kwatia MA, Savage MP, Leonidas DD, Swaminathan GJ, Acharya KR. Charcot-Leyden crystal protein (galectin-10) is not a dual-function galectin with lysophospholipase activity, but binds a lysophospholipase inhibitor in a novel structural fashion. J Biol Chem 2002;277:14859-14868.
4. Than NG, Pick E, Bellyei S, Szigeti A, Burger O, Berente Z, Janaky T, Boronkai A, Kliman H, Meiri H, Bohn H, Than GN, Sumegi B. Functional analyses of placental protein 13/galectin-13. Eur J Biochem 2004;271:1065-1078.
5. Cooper DNW, Barondes SH. God must love galectins; He made so many of them. Glycobiology 1999;9:979-984.
6. Perillo NL, Pace KE, Seilhamer JJ, Baum LG. Apoptosis of T-cells mediated by galectin-1. Nature 1995;378:736-739.
7. Yang RY, Hsu DK, Liu F-T. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 1996;93 (13):6737-6742.
8. Pace KE, Lee C, Stewart PL, Baum LG. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol 1999;163:3801-3811.
9. Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hirabayashi J, Chernajovsky Y. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 1999;190 (3):385-398.
10. Pace KE, Hahn HP, Pang M, Nguyen JT, Baum LG. Cutting edge: CD7 delivers a proapoptotic signal during galectin-1-induced T cell death. J Immunol 2000;165:2331-2334.
11. Fischer C, Sanchez-Ruderisch H,Welzel M,Wiedenmann B, Sakai T, Andr S, Gabius H-J, Khachigian L, Detjen KM, Rosewicz S. Galectin-1 interacts with the a5b1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J Biol Chem 2005;280 (44):37266-37277.
12. Cho M, Cummings RD. Galectin-1, a beta-galactose-binding lectin in Chinese hamster ovary cells. II. Localization and biosynthesis. J Biol Chem 1995;270:5207-5212.
13. Cho M, Cummings RD. Galectin-1, a beta-galactose-binding lectin in Chinese hamster ovary cells. I. Physical and chemical characterization. J Biol Chem 1995;270: 5198-5206.
14. Houzelstein D, Concalves IR, Fadden AJ, Sidhu SS, Cooper DNW, Drickamer K, Leffler H, Poirier F. Phylogenetic analysis of the vertebrate galectin family. Mol Biol Evol 2004;21:1177-1187.
15. Stowell SR, Dias-Baruffi M, Penttila L, Renkonen O, Nyame AK, Cummings RD. Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides. Glycobiology 2004;14:157-167.
16. Poirier F, Robertson EJ. Normal development of mice carrying a null mutation in the gene encoding the L 14 S-type lectin. Development 1993;119:1229-1236.
17. Tenne-Brown J, Puche AC, Key B. Expression of galectins-1 in the mouse olfactory system. Int J Dev Biol 1998;42:791-799.
18. McGraw J, Gaudet AD, Oschipok LW, Steeves JD, Poirier F, Tetzlaff W, Ramer MS. Altered primary afferent anatomy and reduced thermal sensitivity in mice lacking galectins-1. Pain 2005;114:7-18.
19. Hsu DK, Yang R-Y, Pan Z, Yu L, Salomon DR, Fung-Leung W-P, Liu F-T. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 2000;156:1073-1083.
20. Nedwin G, Bringman T, Conraud P-O. US Patent 5,633,148. 1997.
21. Rousseau C, Muriel MP, Musset M, Botti J, Seve AP. Glycosylated nuclear lectin CBP70 also associated with endoplasmic reticulum and the Golgi apparatus: does the ''classic pathway'' of glycosylation also apply to nuclear glycoproteins? J Cell Biochem 2000;78: 638-649.
22. Rousseau C, Felin M, Doyennette-Moyne MA, Seve AP. CBP70, a glycosylated nuclear lectin. J Cell Biochem 1997;66:370-385.
23. Rousseau C, Felin M, Seve AP. Stable expression of functional CBP70 lectin during heat shock. J Cell Biochem 2000;77:615-623.
24. Facy P, Seve AP, Hubert M, Monsigny M, Hubert J. Analysis of nuclear sugar-binding components in undifferentiated and in vitro differentiated human promyelocytic leukemia cells (HL60)Exp Cell Res 1990;190:151-160.
25. Felin M, Doyennette-Moyne MA, Hadj-Sahraoui Y, Aubery M, Hubert J, Seve AP. Identification of two nuclear N-acetylglucosamine-binding proteins. J Cell Biochem 1994;56:527-535.
26. Lefebvre T, Cieniewski C, Lemoine J, Guerardel Y, Leroy Y, Zanetta JP, Michalski JC. Identification of N-acetyl-D-glucosamine-specific lectins from rat liver cytosolic and nuclear compartments as heat-shock proteins. Biochem J 2001;360:179-188.
27. Rondanino C, Bousser M-T, Monsigny M, Roche A-C. Sugar-dependent nuclear import of glycosylated proteins in living cells. Glycobiology 2003;13 (7):509-519.
28. Guinez C, Losfeld M-E, Cacan R, Michalski J-C, Lefebvre T. Modulation of HSP70 GlcNAc-directed lectin activity by glucose availability and utilization. Glycobiology 2006;16:22-28.
29. Elola MT, Chiesa ME, Alberti AF, Mordoh J, Fink NE. Galectin-1 receptors in different cell types. J Biomed Sci 2005;12:13-29.
30. Bohn H, Kraus W, Winckler W. Purification and characterization of two new soluble placental tissue proteins (PP13 and PP17). Oncodev Biol Med 1983;4:343-350.
31. Tinari N, Kuwabara I, Huflejt ME, Shen PF, Iacobelli S, Liu F-T. Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation. Int J Cancer 2000;91:167-172.
32. Kuwabara I, Liu F-T. Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 1996;156:3939-3944.
33. Inohara H, Akahani S, Koths K, Raz A. Interactions between galectin-3 and Mac-2- binding protein mediate cell-cell adhesion. Cancer Res 1996;56:4530-4534.
34. Kopitz J, von Reitzenstein C, Andre S, Kaltner H, Uhl J, Ehemann V, Cantz M, Gabius H-J. Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem 2001;276:35917-35923.
35. Brewer CF. Binding and cross-linking properties of galectins. Biochim Biophys Acta 2002;1572:255-262.
36. Ahmad N, Gabius H-J, Sabesan S, Oscarson S, Brewer CF. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3. Glycobiology 2004;14:817-825.
37. Ahmad N, Gabius H-J, Andre S, Kaltner H, Sabesan S, Roy R, Liu B, Macaluso F, Brewer CF. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J Biol Chem 2004;279 (12):10841-10847.
38. Mandal DK, Brewer CF. Cross-linking activity of the 14-kilodalton b-galactose-specific vertebrate lectin with asialofetuin: comparison with several galactose-specific plant lectins. Biochemistry 1992;31:8465-8472.
39. Gupta D, Kaltner H, Dong X, Gabius H-J, Brewer CF. Comparative cross-linking activities of lactose-specific plant and animal lectins and a natural lactose-binding immunoglobulin G fraction from human serum with asialofetuin. Glycobiology 1996;6:843-849.
40. Zou J, Glinsky VV, Landon LA, Matthews L, Deutscher SL. Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. Carcinogenesis 2005;26:309-319.
41. Cumpstey I, Sundin A, Leffler H, Nillson UJ. C2-symmetrical thiodigalactoside bis-benzamido derivatives as high-affinity inhibitors of galectin-3: efficient lectin inhibition through double arginine-arene interactions. Angew Chem Int Ed Engl 2005;44:5110-5112.
42. Fort S, Kim H-S, Hindsgaul O. Screening for galectin-3 inhibitors from synthetic lacto-Nbiose libraries using microscale affinity chromatography coupled to mass spectrometry. J Org Chem 2006;71:7146-7154.
43. Mandal TK, Mukhopadhyay C. Binding free energy calculations of galectin-3-ligand interactions. Protein Eng 2002;15:979-986.
44. Ahmed H, Bianchet MA, Amzel LM, Hirabayashi J, Kasai K-I, Giga-Hama Y, Tohda H, Vasta GR. Novel carbohydrate specificity of the 16-kDa galectin from Caenorhabditis elegans: binding to blood group precursor oligosaccharides (type 1, type 2, Ta, and Tb) and gangliosides. Glycobiology 2002;12:451-461.
45. Ingrassia L, Camby I, Lefranc F, Mathieu V, Nshimyumukiza P, Darro F, Kiss R. Anti-galectin compounds as potential anti-cancer drugs. Curr Med Chem 2006;13: 3513-3527.
46. Tejler J, Leffler H, Nilsson UJ. Synthesis of O-galactosyl aldoximes as potent LacNAc-mimetic galectin-3 inhibitors. Bioorg Med Chem Lett 2005;15:2343-2345.
47. Salameh BA, Sundin A, Leffler H, Nilsson UJ. Thioureido N-acetyllactosamine derivatives as potent galectin-7 and 9N inhibitors. Bioorg Med Chem 2006;14: 1215-1220.
48. Sörme P, Qian Y, Nyholm P-G, Leffler H, Nilsson UJ. Low micromolar inhibitors of galectin-3 based on 30-derivatization of N-acetyllactosamine. ChemBioChem 2002;3: 183-189.
49. Sörme P, Kahl-Knutsson B, Wellmar U, Magnusson B-G, Leffler H, Nilsson UJ. Design and synthesis of galectin inhibitors. Methods Enzymol 2003;363:157-169.
50. Sörme P, Arnoux P, Kahl-Knutsson B, Leffler H, Rini JM, Nilsson UJ. Structural and thermodynamic studies on galectin-3 in complex with synthetic inhibitors: carbohydrate -protein affinity enhancements through fine-tuning of an arginine-arene interaction. J Am Chem Soc 2005;127:1737-1743.
51. Ideo H, Seko A, Ohkura T, Matta KL, Yamashita K. High-affinity binding of recombinant human galectin-4 to SO3-!3Galb1!3GalNAc pyranoside. Glycobiology 2002;12: 199-208.
52. Hsu DK, Zuberi RI, Liu FT. Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin. J Biol Chem 1992;267: 14167-14174.
53. Sparrow CP, Leffler H, Barondes SH. Multiple soluble b-galactoside-binding lectins from human lung. J Biol Chem 1987;262:7383-7390.
54. Ahmad N, Gabius HJ, Kaltner H, Andre S, Kuwabara I, Liu F-T, Oscarson S, Norberg T, Brewer CF. Thermodynamic binding studies of cell surface carbohydrate epitopes to galectins-1, -3, and -7: evidence for differential binding specificities. Can J Chem 2002;80: 1096-1104.
55. Dyer KD, Rosenberg HF. Eosinophil Charcot-Leyden crystal protein binds to beta-galactoside sugars. Life Sci 1996;58:2073-2082.
56. Schwarz FP, Ahmed H, Bianchet MA, Amzel LM, Vasta GR. Thermodynamics of bovine spleen galectins-1 binding to disaccharides: correlation with structure and its effect on oligomerization at the denatured temperature. Biochemistry 1998;37: 5867-5877.
57. Leffler H, Barondes SH. Specificity of binding of three soluble rat lung lectins to substituted and unsubstituted mammalian beta-galactosides. J Biol Chem 1986;261: 10119-10126.
58. Appukuttan PS. Terminal alpha-linked galactose rather than N-acetyl lactosamine is ligand for bovine heart galectin-1 in N-linked oligosaccharides of glycoproteins. J Mol Recognit 2002;15:180-187.
59. Carlsson S, Oberg CT, Carlsson MC, Sundin A, Nilsson UJ, Smith D, Cummings RD, Almkvist J, Karlsson A, Leffler H. Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Glycobiology 2007;17:663-676.